Work

Discovery of Clinical Candidate (5-(3-(4-Chlorophenoxy)prop-1-yn-1-yl)-3-hydroxypicolinoyl)glycine, an Orally Bioavailable Prolyl Hydroxylase Inhibitor for the Treatment of Anemia

Year: 2020

Type: article

Source: Journal of Medicinal Chemistry

DOI: 10.1021/acs.jmedchem.0c01161

Authors: Xiaojin Zhang, Yonghua Lei, Tianhan Hu, Yue Wu, Zhihong Li, Zhensheng Jiang, Changyong Yang, Lianshan Zhang, Qidong You

Institutions: China Pharmaceutical University, State Key Laboratory of Natural Medicine

Language: English

Topic: Erythropoietin and Anemia Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China, Government of Jiangsu Province, State Key Laboratory of Natural Medicines

Awards: G2656922425, G4825520842, G5650194533, G8496734291, G904408397

OpenAlex ID: W3045831722

FWCI: 2.872

Cites: 34

Cited by: 27

Related to: 10

Parts: 2